GDTC
CytoMed Therapeutics Limited Ordinary Shares
NASDAQ: GDTC · HEALTHCARE · BIOTECHNOLOGY
$1.00
+0.71% today
Updated 2026-04-30
Market cap
$11.60M
P/E ratio
—
P/S ratio
13.47x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
CytoMed Therapeutics Limited Ordinary Shares (GDTC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-535.00%
ROE
-50.30%
ROA
-29.30%
Debt/equity
0.07x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-632611.00 | — | — | — |
| 2020 | $44923.00 | $-1.47M | 92.22% | -2,233.00% | -3,266.07% |
| 2021 | $84178.00 | $-1.53M | 96.92% | -1,661.39% | -1,822.31% |
| 2022 | $270335.00 | $-2.27M | -29.98% | -627.66% | -839.94% |
| 2023 | $290560.00 | $-3.13M | 131.44% | -1,100.96% | -1,077.85% |
| 2024 | $52005.00 | $-1.88M | 100.72% | -5,049.84% | -3,621.15% |
| 2025 | $248269.00 | $-3.05M | -277.74% | -1,415.96% | -1,227.07% |